Drug Trial Radar · NCT07455825
A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years
Last checked: Nov 19, 2026Latest source record: Jun 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
65
Actual
Start
Mar 5, 2026
Primary completion
Jun 1, 2026
Study completion Jun 1, 2026
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- Collaborators
- Parexel
- First posted
- Mar 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the pharmacokinetics (PK), safety and tolerability of different oral formulations of AZD5004, and to evaluate the effect of food on these formulations in healthy participants.
Conditions
- Healthy Participants
Interventions
AZD5004Drug
AZD5004 will be administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area under concentration-time curve from time 0 extrapolated to infinity (AUCinf)Time frame: From Day 1 to Day 22
- Area under concentration-curve from time 0 to the time of last quantifiable concentration (AUClast)Time frame: From Day 1 to Day 22
- Maximum observed concentration (Cmax)Time frame: From Day 1 to Day 22
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Glendale, California
Research Site
Baltimore, Maryland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.